What's new

Human medicines European public assessment report (EPAR): Ogluo, glucagon, Date of authorisation: 11/02/2021, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR): Ogluo, glucagon, Date of authorisation: 11/02/2021, Revision: 7, Status: Authorised

May 16, 2025 - 14:50
 0
Human medicines European public assessment report (EPAR): Ogluo, glucagon, Date of authorisation: 11/02/2021, Revision: 7, Status: Authorised
Human medicines European public assessment report (EPAR): Ogluo, glucagon, Date of authorisation: 11/02/2021, Revision: 7, Status: Authorised
Read More

Tags:

Previous Article

Amgen loses $400 million antitrust battle to Regeneron

Next Article

Human medicines European public assessment report (EPAR): Lyvdelzi (previously S...

Related Posts

Agenda of the COMP meeting 13-15 May 2025

May 14, 2025  0

Human medicines European public assessment report (EPAR): Cibinqo, abrocitinib, Date of authorisation: 09/12/2021, Revision: 14, Status: Authorised

Human medicines European public assessment report (EPAR...

May 7, 2025  0

Summary of changes to the ‘External guidance on the imp...

May 15, 2025  0